Masson Philip, Kelly Patrick J, Craig Jonathan C, Lindley Richard I, Webster Angela C
Sydney School of Public Health and Centre for Kidney Research, Children's Hospital at Westmead, Westmead, New South Wales, Australia; and
Sydney School of Public Health and.
Clin J Am Soc Nephrol. 2015 Sep 4;10(9):1585-92. doi: 10.2215/CJN.12001214. Epub 2015 Jul 24.
This study aimed to determine absolute and excess stroke risks in people with ESRD compared with the general population.
DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: This cohort study used data linkage between the Australia and New Zealand Dialysis and Transplant Registry and hospital and death records for 10,745 people with ESRD in New South Wales from 2000 to 2010. For the general population, Australian Institute of Health and Welfare hospital usage records and Australian Bureau of Statistics census data were used. Rates and standardized incidence rate ratios of hospitalization with a stroke were calculated.
People with ESRD had 640 hospitalizations with stroke in 49,472 person-years of follow-up (1294 per 100,000 person-years), and people in the general population had 338,392 hospitalizations with stroke (212 per 100,000 person-years), an incidence rate ratio of 3.32 (95% confidence interval, 3.31 to 3.33). Excess risk was greater for women (incidence rate ratio, 5.14; 95% confidence interval, 5.11 to 5.18) than men (incidence rate ratio, 2.52; 95% confidence interval, 2.51 to 2.54; P for interaction <0.001) and decreased with age. People ages 35-39 years old with ESRD had an 11 times increased risk of stroke (incidence rate ratio, 11.08; 95% confidence interval, 9.41 to 13.05), and risk in people ages ≥85 years old increased 2-fold (incidence rate ratio, 2.04; 95% confidence interval, 1.87 to 2.23; P for interaction <0.001). Excess risk was greater for intracerebral hemorrhage (incidence rate ratio, 4.18; 95% confidence interval, 4.11 to 4.26) than ischemic stroke (incidence rate ratio, 3.43; 95% confidence interval, 3.40 to 3.45; P for interaction <0.01).
People with ESRD have a substantially higher risk of stroke, particularly women and young people, and hemorrhagic stroke. Future work could investigate effective and safe interventions for primary and secondary prevention of stroke in people with ESRD.
本研究旨在确定与普通人群相比,终末期肾病(ESRD)患者发生卒中的绝对风险和额外风险。
设计、研究地点、参与者及测量方法:这项队列研究利用了澳大利亚和新西兰透析与移植登记处与新南威尔士州10745例ESRD患者2000年至2010年的医院及死亡记录之间的数据链接。对于普通人群,使用了澳大利亚卫生与福利研究所的医院使用记录以及澳大利亚统计局的人口普查数据。计算了卒中住院率和标准化发病率比。
在49472人年的随访中,ESRD患者中有640例卒中住院(每10万人年1294例),普通人群中有338392例卒中住院(每10万人年212例),发病率比为3.32(95%置信区间为3.31至3.33)。女性的额外风险(发病率比为5.14;95%置信区间为5.11至5.18)高于男性(发病率比为2.52;95%置信区间为2.51至2.54;交互作用P<0.001),且随年龄降低。35至39岁的ESRD患者发生卒中的风险增加了11倍(发病率比为11.08;95%置信区间为9.41至13.05),85岁及以上人群的风险增加了2倍(发病率比为2.04;95%置信区间为1.87至2.23;交互作用P<0.001)。脑出血的额外风险(发病率比为4.18;95%置信区间为4.11至4.26)高于缺血性卒中(发病率比为3.43;95%置信区间为3.40至3.45;交互作用P<0.01)。
ESRD患者发生卒中的风险显著更高,尤其是女性和年轻人,以及出血性卒中。未来的工作可以研究针对ESRD患者卒中一级和二级预防的有效且安全的干预措施。